December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
A Potential Role For Thombospondin In Corneal Endothelial Cell Injury
Author Affiliations & Notes
  • JM Doherty
    Schepens Eye Research Institute Harvard Medical School Boston MA
  • B Turpie
    Schepens Eye Research Institute Harvard Medical School Boston MA
  • S Masli
    Schepens Eye Research Institute Harvard Medical School Boston MA
  • JW Streilein
    Schepens Eye Research Institute Harvard Medical School Boston MA
  • Footnotes
    Commercial Relationships   J.M. Doherty, None; B. Turpie, None; S. Masli, None; J.W. Streilein, None. Grant Identification: NIH Grant EY10765
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2265. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JM Doherty, B Turpie, S Masli, JW Streilein; A Potential Role For Thombospondin In Corneal Endothelial Cell Injury . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2265.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Thrombospondin (TSP), a matrix glycoprotein is recognized for its potent anti-angiogenic properties. For example, TSP while present in normal aqueous humor (AqH) is decreased in AqH obtained from diseased diabetic eyes suggesting a role for TSP in ocular damage. The goal of the present study is to examine the role of TSP in the regulation of corneal endothelial cell responses to inflammatory cell injuries/assaults. Methods: Immortalized BALB/c corneal endothelial cells (CE) were grown to confluence in RPMI medium + 10% FBS. Cells were incubated for 24 hrs in serum-free, phenol-free RPMI or in RPMI containing the following inflammatory agents: LPS (100 ng/ml); IFN-γ (500 U/ml); LPS/IFN-γ in combination; or TNF-α (50 ng/ml). TSP levels in CE were measured by RT-PCR and indirect immunocytochemistry. In separate experiments, exogenous TSP (1.0 µg and 0.1 µg/ml) was added to parallel cultures and CE status determined by 3H-Thymidine (3H) uptake and positive staining for Ki67, a marker of cell proliferation. Results: Cultured CE expressed TSP constitutively. Neither LPS nor IFN-γ added singularly affected TSP levels in CE. The addition of TNF-α to CE resulted in their decreased expression of TSP. In contrast, the addition of LPS/IFN-γ in combination elicited an increase in CE TSP expression. Both the addition of LPS/IFN-γ and TNF-α to CE resulted in a 41 and 29.2 % inhibition of CE proliferation, respectively when assessed by 3H-Thymidine uptake. The addition of exogenous TSP had no effect on 3H uptake either in control or LPS/IFN-γ treated CE. However, TSP restored proliferation of TNF-α treated CE to a level 1.75 fold greater than that observed with control CE. Conclusion: Corneal endothelial cells constitutively express TSP. Expression of TSP is altered upon exposure of CE to inflammatory agents such as LPS/IFN-γ and TNF-α. We suggest that CE may use thrombospondin to maintain cellular homeostasis.

Keywords: 371 cornea: endothelium • 437 inflammation • 435 immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×